Rubén is a native of Nayarit, México, where he completed studies in sustainable aquaculture and following his passion for all life, a bachelor in biology in Ensenada, Baja California. After moving to the United States in 1994, Rubén received a Doctorate in chemistry and biochemistry from UCLA and soon after began his career in the San Diego biotechnology industry. Rubén has held a variety of positions in R&D, marketing, business development and technology commercialization. His professional career includes Becton Dickinson (PharMingen) and Biosite (now Alere), where he ran worldwide clinical trials to develop a life-saving bedside diagnostic for sepsis; Rubén later joined Chemicon (now Millipore-Sigma), where he managed R&D, worldwide clinical-trial operations, and marketing activities for the diagnosis of viral infections. While at Millipore-Sigma, Rubén founded the world-wide Scientific Collaborations group, tasked with developing novel solutions with academic partners across the globe for stem cell research, biomarkers, cancer, neuroscience, diagnostics and therapeutics. Most recently, Rubén served as Vice President of Business Development and Technology Transfer for LA BioMed at Harbor UCLA Medical Center (an L.A. County hospital providing care to the underserved population and featured in the popular 1970’s series, Emergency!), where he focused his efforts on fostering the entrepreneurial ecosystem for startups. Working with local academic centers, the County of Los Angeles, LAEDC, LARTA and local REITs, Rubén championed the development of a 300,000 sq foot biotech park on the Harbor UCLA campus (the first of its kind in Los Angeles). Rubén is a strong supporter of the regional innovation ecosystem. He has lent his expertise as a past member of BIOCOM’s FDA committee. Rubén has acted as a member of the Scientific Advisory board of UC Riverside’s department of Bioengineering, the advisory board to the Coulter Translational Research Partnership Program at the departments of Bioengineering at the University of Washington and at the University of Southern California, and the advisory board for graduate programs in Biotechnology at Cal State University San Marcos.